A White Paper, from Brian McMillan

The Journey of Bravado Pharmaceutcals and the Development of CoVer Nasal Antibody Drops

Bravado invites you to read a white paper recently written by our founder, Brian McMillan, for Pharmaceutical Technology regarding development of "Cover Nasal Antibody Drops" during the CV-19 pandemic.

Bravado Pharmaceuticals developed this product in conjunction with Stanford University and SPARKGLOBAL.

The program was led by Professor Daria Mochly Rosen of Stanford and SPARKGLOBAL.

See our White Paper HERE